CARILLON TOWER ADVISERS, INC. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 182 filers reported holding HERON THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 0.73 and the average weighting 0.4%.

Quarter-by-quarter ownership
CARILLON TOWER ADVISERS, INC. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q2 2019$23,696,000
-23.9%
1,274,6950.0%0.16%
-25.9%
Q1 2019$31,153,000
-5.8%
1,274,6950.0%0.22%
-21.4%
Q4 2018$33,066,000
-18.0%
1,274,6950.0%0.28%
-3.1%
Q3 2018$40,344,000
-18.5%
1,274,6950.0%0.29%
-25.9%
Q2 2018$49,521,000
+47.2%
1,274,6950.0%0.39%
+48.9%
Q1 2018$33,651,0001,274,6950.26%
Other shareholders
HERON THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders